Navigation Links
Remodulin in Medical News

FDA Approves Remodulin for Pulmonary Hypertension

According to a notice distributed by the agency, the US Food and Drug Administration (FDA) has approved United Therapeutics Corp.'s pulmonary arterial hypertension therapy Remodulin (treprostinil sodium). A spokesperson for the FDA told Reuters Health that the approved indication covers NYHA class ...

Hissey Kientz Announces the Launch of Herbal Fen Phen Lawyers Website

...octor may prescribe a number of possible treatments. These can include prescription medications such as Letairis, warfarin, Digitek (digoxin), Flonan, remodulin or Tracleer; as well as changes in a patient’s diet or mild exercise. A lung or heart transplant may be necessary depending on how soon a diagno...

United Therapeutics Corporation Reports Second Quarter 2009 Financial Results

...e or revise the information contained in this press release whether as a result of new information, future events or any other reason. [uthr-e] remodulin and Tyvaso are trademarks of United Therapeutics Corporation. Adcirca is a trademark of Eli Lilly and Company. UNITE...

FDA Approves TYVASO (Treprostinil) Inhalation Solution for the Treatment of Pulmonary Arterial Hypertension

... vasculature. TYVASO contains the same active ingredient (treprostinil) as remodulin (treprostinil sodium) Injection, which is also approved for the treatment o...sult of new information, future events or any other reason. [uthr-g] remodulin is a registered trademark of United Therapeutics Corporation. TYVASO is a...

United Therapeutics Reports 2008 Fourth Quarter and Annual Financial Results

... 2008 2007 2008 2007 Revenues: remodulin $73,137 $56,824 $269,718 $200,879 Telemedicine...ether as a result of new information, future events or any other reason. remodulin is a registered trademark of United Therapeutics Corporation. AERx Essen...

Triumph-1 Trial of Viveta in Pulmonary Arterial Hypertension Meets Primary Endpoint

...in this press release whether as a result of new information, future events or any other reason. [uthr-g] Viveta is a trademark of Lung Rx, Inc., and remodulin is a registered trademark of United Therapeutics Corporation. Tracleer is a registered trademark of Actelion Ltd. Revatio is a registered trademark ...
Remodulin in Medical Technology

Treprostinil Data Presented at American Thoracic Society Conference Demonstrates Significant Clinical Progress in All Four Routes of Administration

...intravenous Remodulin. Rapid switch from Flolan to remodulin occurred by directly switching the infusion pump r...s on drug preparation decreased by 44 percent with remodulin as compared to Flolan. In Multi-Center Experienc...ason for transition. Most patients transitioned to remodulin in an inpatient setting, but many patients were su...
Remodulin in Biological Technology

United Therapeutics Reports First Quarter 2009 Financial Results

...s' Chairman and Chief Executive Officer. "Our core remodulin franchise continues to grow and is now the preferr... including the growth and market prominence of our remodulin business and our belief about the future prospects...information, future events or any other reason. remodulin is a registered trademark of United Therapeutics C...

United Therapeutics Reports Third Quarter 2008 Financial Results

...on to update or revise the information contained in this press release whether as a result of new information, future events or any other reason. remodulin is a registered trademark of United Therapeutics Corporation. [uthr-g] UNITED THERAPEUTICS CORPORATION CONSOLI...

United Therapeutics Reports Second Quarter 2008 Financial Results

...plishments reflect the decisions of hundreds of doctors and patients to use remodulin and make it the leading form of prostacyclin therapy in the United States."...her as a result of new information, future events or any other reason. remodulin is a registered trademark of United Therapeutics Corporation. [uthr-g] ...

United Therapeutics Reports First Quarter 2008 Financial Results

...ion to update or revise the information contained in this press release whether as a result of new information, future events or any other reason. remodulin is a registered trademark of United Therapeutics Corporation. [uthr-g] UNITED THERAPEUTICS CORPORATION CONSOLID...

United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results

...ion to update or revise the information contained in this press release whether as a result of new information, future events or any other reason. remodulin is a registered trademark of United Therapeutics Corporation. OvaRex is a registered trademark of AltaRex Medical Corp. UNITE...

United Therapeutics Reports Third Quarter 2007 Financial Results

... update or revise the information contained in this press release whether as a result of new information, future events or any other reason. [uthr-g] remodulin and HeartBar are registered trademarks of United Therapeutics Corporation. Beraprost is a trademark of Toray Industries, Inc. OvaRex is a registered...
Other Tags
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. ... in treating respiratory syncytial virus (RSV), a leading cause of ... major progress in being able to treat human RSV infections ... second only to influenza virus," said study author Dr. John ... College of Medicine in Memphis. "There is no ...
(Date:8/21/2014)... According to the new report “Waterborne Coatings ... PTFE, PVDF, PVDC, & Others), by Application (Architectural, ... & Others) - Global Forecast to 2019” published ... estimated to reach $77,838.71 Million by 2019. , ... spread through 225 Slides and in-depth TOC on ...
(Date:8/21/2014)... (PRWEB) August 21, 2014 According to ... "Enteral Feeding Devices Market (Enteral Feeding Tubes, Enteral Feeding ... Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 ... valued at USD 2.0 billion in 2012 and is ... billion in 2019growing at a CAGR of 6.2% from ...
(Date:8/21/2014)... polio is considered nearly eradicated. Each year only a ... the University of Bonn, together with colleagues from Gabon, ... able to resist the vaccine protection to a considerable ... the Congo in 2010. The pathogen could also potentially ... now in the magazine PNAS . , The ...
(Date:8/21/2014)... One of the emerging trends that the Intranasal ... increasing adoption of non-invasive administration products. As non-invasive nasal ... their convenient application, they find more preference among end-users. ... used for the administration of drugs for the treatment ... such as allergic and non-allergic rhinitis and sinusitis. The ...
Breaking Medicine News(10 mins):Health News:New Drug May Fight Serious Respiratory Virus in Infants 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 3Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 2Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 3Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 4Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 2Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 3Health News:Enteral Feeding Devices Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 4Health News:Polio: Mutated virus breaches vaccine protection 2Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 2Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 3Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 4Health News:Intranasal Drug Delivery Market 2014 – 2018 Global Forecasts and Analysis in New Research Report at Sandlerresearch.org 5
(Date:8/20/2014)... who are poor experience higher cortisol levels in pregnancy ... the stress hormone, putting them at greater risk ... new research from the University of Colorado Denver. , ... Journal of Human Biology , is the first to ... the socioeconomic status of their mothers during pregnancy. , ...
(Date:8/20/2014)... State University researchers have developed methods for electronically manipulating ... electrical signals moths use to control those muscles. The ... moths, or "biobots," for use in emergency response. , ... we can control the movement of moths for use ... Dr. Alper Bozkurt, an assistant professor of electrical and ...
(Date:8/20/2014)...  The second annual Biometrics UnPlugged Executive Summit, ... Florida on September 15, 2014, will ... and Strategy at Samsung, and Philippe de Raet, Vice ... this year,s event is Mobility at the Crossroads ... UnPlugged: Mobility at the Crossroads of Commerce & ...
Breaking Biology News(10 mins):CU Denver researcher shows economic disparities impact infant health 2Research paves way for development of cyborg moth 'biobots' 2Biometrics UnPlugged: Mobility at the Crossroads of Commerce & Privacy to Feature Interactive Sessions with Samsung and Experian 2
Other Contents